ACAPPELLA Study
Natural History Study of Homocystinuria Caused by Cystathionine Beta-synthase Deficiency
Therapeutic area: HCU
Study type: Observational
Learn more: hcuconnection.com | NCT02998710
EPPIK Study
Sparsentan Treatment in Pediatrics with Proteinuric Glomerular Diseases (EPPIK)
Therapeutic area: FSGS; IgAN
Study type: Phase 2
Learn more: eppikclinicalstudy.com | NCT05003986
SPARTACUS Study
A Study to Investigate Safety and Effect of Sparsentan in Combination With SGLT2 Inhibition in Participants With IgAN (SPARTACUS)
Therapeutic area: IgAN
Study type: Phase 2
Learn more: NCT05856760
HARMONY Study
Investigational therapy: Pegtibatinase (TVT-058)
Therapeutic area: HCU
Study type: Interventional
Learn more: NCT06247085
In September 2024, Travere voluntarily paused the enrollment in the HARMONY Study due to commercial manufacturing scale-up. Read the press release>
COMPOSE Study
Investigational therapy: Pegtibatinase (TVT-058)
Therapeutic area: HCU
Study type: Phase 1/2
Learn more: hcuconnection.com | NCT03406611
